Pharmabiz43m
EU looks at India as best option over China, reflecting potential shifts in trade dynamics
EU looks at India as best option over China, reflecting potential shifts in trade dynamics: Nandita Vijayasimha, Bengaluru Saturday, January 11, 2025, 08:00 Hrs [IST] The European ...
Pharmabiz43m
Dr D Ramanathan wins Dhanwanthari Award for his contributions to Ayurveda
Dr D Ramanathan, managing director of Sitaram Ayurveda Pharmacy, Thrissur and general secretary of the Ayurveda Medicine ...
Pharmabiz43m
SMPMA urges govt to drop conditions mandated for extension of revised Schedule M implementation
SMPMA urges govt to drop conditions mandated for extension of revised Schedule M implementation: Gireesh Babu, New Delhi Saturday, January 11, 2025, 08:00 Hrs [IST] The Delhi-base ...
Pharmabiz43m
IDMA plans extensive workshops on revised Schedule M to assist pharma MSMEs
IDMA plans extensive workshops on revised Schedule M to assist pharma MSMEs: Shardul Nautiyal, Mumbai Saturday, January 11, ...
Pharmabiz43m
NPPA recalculates ceiling price of azithromycin 250 mg following review order
NPPA recalculates ceiling price of azithromycin 250 mg following review order: Gireesh Babu, New Delhi Saturday, January 11, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pric ...
Pharmabiz17h
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai
Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...
Pharmabiz19h
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa: Our Bureau, Mumbai ...
Pharmabiz7d
Centre notifies amendments to Foreign Trade Policy 2023 to enhance stakeholder engagement
The Union ministry of commerce & industry has issued a notification introducing amendments to the Foreign Trade Policy (FTP) 2023, aimed at fostering enhanced stakeholder engagement. The notification, ...
Pharmabiz6d
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps
GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...
Pharmabiz6d
Artificial intelligence and machine learning transforming ICU decision-making: Experts
Artificial intelligence (AI) and machine learning (ML) are poised to redefine the landscape of critical care medicine, offering innovative solutions to the challenges faced in intensive care units ...
Pharmabiz6d
SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses
SIGA Technologies, a commercial stage pharmaceutical company, announced that its antiviral treatment Tepoxx (tecovirimat 200 mg capsules), marketed as Tpoxx in the United States, has received ...
Pharmabiz6d
Radius Pharma grants Pharmanovia the exclusive commercialization rights to abaloparatide in China and selected Asia Pacific territories
Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc., a specialty biopharmaceutical company focused on bone health and related areas, announced that it has granted ...